6-APB.jpg
This image contains
digital watermarking
or credits in the image itself
. The usage of visible watermarks is
discouraged
. If a non-watermarked version of the image is available,
please upload it under the same file name
and then
remove this template
. Ensure that removed information is present in the image description page and replace this template with
{{Metadata from image}}
or
{{Attribution metadata from licensed image}}
.
Caution: Before removing a watermark from a copyrighted image, please read the WMF's analysis of the legal ramifications of doing so, as well as Commons' proposed policy regarding watermarks. If the old version is still useful, for example if removing the watermark damages the image significantly, upload the new version under a different title so that both can be used. After uploading the non-watermarked version, replace this template with
{{
Superseded
|
new filename
|version without watermarks}}
.
Bahasa Indonesia ∙ italiano ∙ eesti ∙ sicilianu ∙ Deutsch ∙ català ∙ magyar ∙ čeština ∙ română ∙ español ∙ português ∙ English ∙ hrvatski ∙ Plattdüütsch ∙ français ∙ Nederlands ∙ polski ∙ galego ∙ slovenščina ∙ suomi ∙ svenska ∙ Ελληνικά ∙ беларуская (тарашкевіца) ∙ български ∙ македонски ∙ русский ∙ українська ∙ മലയാളം ∙ ไทย ∙ 日本語 ∙ 中文 ∙ 中文(简体) ∙ 中文(繁體) ∙ עברית ∙ العربية ∙ فارسی ∙ +/− |
Summary
Description 6-APB.jpg |
English:
6-APB is an empathogen/entactogen of the substituted benzofuran, substituted amphetamine and substituted phenethylamine classes.
|
||
Date | |||
Source | Own work . Originally published in The Honest Drug Book [ISBN: 978-0995593602]. | ||
Author | DMTrott | ||
Permission
( Reusing this file ) |
|
6-APB is frequently referred to as Benzo Fury or Benzofury.
Licensing
-
You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
-
Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- share alike – If you remix, transform, or build upon the material, you must distribute your contributions under the same or compatible license as the original.